{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T04:12:54Z","timestamp":1793160774319,"version":"4.5.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T00:00:00Z","timestamp":1728432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T00:00:00Z","timestamp":1728432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1038\/s41380-024-02753-9","type":"journal-article","created":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T08:02:47Z","timestamp":1728460967000},"page":"1430-1439","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Sex\/gender effects of glial reactivity on preclinical Alzheimer\u2019s disease pathology"],"prefix":"10.1038","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8779-1487","authenticated-orcid":false,"given":"Clara","family":"Vila-Castelar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muge","family":"Akinci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8478-273X","authenticated-orcid":false,"given":"Eleni","family":"Palpatzis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Aguilar-Dominguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Operto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwendlyn","family":"Kollmorgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9050-3282","authenticated-orcid":false,"given":"Clara","family":"Quijano-Rubio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1890-4193","authenticated-orcid":false,"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3930-4354","authenticated-orcid":false,"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5564-2025","authenticated-orcid":false,"given":"Carles","family":"Falcon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Fauria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6155-0642","authenticated-orcid":false,"given":"Juan Domingo","family":"Gispert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oriol","family":"Grau-Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2993-569X","authenticated-orcid":false,"given":"Marc","family":"Su\u00e1rez-Calvet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7016-7576","authenticated-orcid":false,"given":"Eider M.","family":"Arenaza-Urquijo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the ALFA study","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Anastasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annabella","family":"Beteta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Brugulat-Serrat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Cacciaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Cumplido-Mayoral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba","family":"Ca\u00f1as","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"del Campo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carme","family":"Deulofeu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Dominguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Emilio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Fern\u00e1ndez-Arcos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherezade","family":"Fuentes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Genius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armand","family":"Gonz\u00e1lez-Escalante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"Hern\u00e1ndez-Villamizar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Huguet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"L\u00f3pez-Martos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferran","family":"Lugo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Marne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Mench\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Minguillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiesje","family":"Pelkmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albina","family":"Polo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Pradas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanca","family":"Rodr\u00edguez-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo","family":"S\u00e1nchez-Benavides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahnaz","family":"Shekari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Soteras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Stankeviciute","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Vilanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Vilor-Tejedor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,9]]},"reference":[{"key":"2753_CR1","doi-asserted-by":"crossref","unstructured":"Mielke MM, Aggarwal NT, Vila\u2010Castelar C, Agarwal P, Arenaza\u2010Urquijo EM, Brett B, et al. Consideration of sex and gender in Alzheimer\u2019s disease and related disorders from a global perspective. Alzheimers Dement. 2022;18:2707\u201324.","DOI":"10.1002\/alz.12662"},{"key":"2753_CR2","doi-asserted-by":"crossref","first-page":"5695","DOI":"10.1002\/alz.13844","volume":"20","author":"EM Arenaza-Urquijo","year":"2024","unstructured":"Arenaza-Urquijo EM, Boyle R, Casaletto K, Anstey KJ, Vila-Castelar C, Colverson A, et al. Sex and gender differences in cognitive resilience to aging and Alzheimer\u2019s disease. Alzheimers Dement. 2024;20:5695\u20135719.","journal-title":"Alzheimers Dement"},{"key":"2753_CR3","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1212\/WNL.0000000000002570","volume":"86","author":"EE Sundermann","year":"2016","unstructured":"Sundermann EE, Biegon A, Rubin LH, Lipton RB, Mowrey W, Landau S, et al. Better verbal memory in women than men in MCI despite similar levels of hippocampal atrophy. Neurology. 2016;86:1368\u201376.","journal-title":"Neurology"},{"key":"2753_CR4","doi-asserted-by":"crossref","first-page":"fcaa025","DOI":"10.1093\/braincomms\/fcaa025","volume":"2","author":"LA Digma","year":"2020","unstructured":"Digma LA, Madsen JR, Rissman RA, Jacobs DM, Brewer JB, Banks SJ. Women can bear a bigger burden: Ante-and post-mortem evidence for reserve in the face of tau. Brain Commun. 2020;2:fcaa025.","journal-title":"Brain Commun"},{"key":"2753_CR5","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1002\/alz.12552","volume":"18","author":"C Vila-Castelar","year":"2022","unstructured":"Vila-Castelar C, Tariot PN, Sink KM, Clayton D, Langbaum JB, Thomas RG, et al. Sex differences in cognitive resilience in preclinical autosomal-dominant Alzheimer\u2019s disease carriers and non-carriers: Baseline findings from the API ADAD Colombia Trial. Alzheimers Dement. 2022;18:2272\u201382.","journal-title":"Alzheimers Dement"},{"key":"2753_CR6","volume":"12","author":"EE Sundermann","year":"2020","unstructured":"Sundermann EE, Maki PM, Reddy S, Bondi MW, Biegon A, Initiative ASDN. Women\u2019s higher brain metabolic rate compensates for early Alzheimer\u2019s pathology. Alzheimer\u2019s & Dementia: Diagnosis. Assess Dis Monit. 2020;12:e12121.","journal-title":"Assess Dis Monit"},{"key":"2753_CR7","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1001\/jamaneurol.2014.4821","volume":"72","author":"CR Jack","year":"2015","unstructured":"Jack CR, Wiste HJ, Weigand SD, Knopman DS, Vemuri P, Mielke MM, et al. Age, sex, and APOE \u03b54 effects on memory, brain structure, and \u03b2-amyloid across the adult life span. JAMA Neurol. 2015;72:511\u20139.","journal-title":"JAMA Neurol"},{"key":"2753_CR8","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.jalz.2018.04.010","volume":"14","author":"RF Buckley","year":"2018","unstructured":"Buckley RF, Mormino EC, Amariglio RE, Properzi MJ, Rabin JS, Lim YY, et al. Sex, amyloid, and APOE epsilon4 and risk of cognitive decline in preclinical Alzheimer\u2019s disease: Findings from three well-characterized cohorts. Alzheimers Dement. 2018;14:1193\u2013203.","journal-title":"Alzheimers Dement"},{"key":"2753_CR9","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/ana.24135","volume":"75","author":"A Altmann","year":"2014","unstructured":"Altmann A, Tian L, Henderson VW, Greicius MD. Sex modifies the APOE\u2010related risk of developing Alzheimer disease. Ann Neurol. 2014;75:563\u201373.","journal-title":"Ann Neurol"},{"key":"2753_CR10","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/ana.21843","volume":"67","author":"JC Morris","year":"2010","unstructured":"Morris JC, Roe CM, Xiong C, Fagan AM, Goate AM, Holtzman DM, et al. APOE predicts amyloid\u2010beta but not tau Alzheimer pathology in cognitively normal aging. Ann Neurol. 2010;67:122\u201331.","journal-title":"Ann Neurol"},{"key":"2753_CR11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-018-0453-0","volume":"11","author":"O Hansson","year":"2019","unstructured":"Hansson O, Lehmann S, Otto M, Zetterberg H, Lewczuk P. Advantages and disadvantages of the use of the CSF Amyloid \u03b2 (A\u03b2) 42\/40 ratio in the diagnosis of Alzheimer\u2019s Disease. Alzheimers Res Ther. 2019;11:1\u201315.","journal-title":"Alzheimers Res Ther"},{"key":"2753_CR12","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1212\/01.WNL.0000123249.58898.E0","volume":"62","author":"N Schoonenboom","year":"2004","unstructured":"Schoonenboom N, Pijnenburg Y, Mulder C, Rosso S, Van Elk E-J, Van Kamp G, et al. Amyloid \u03b2 (1\u201342) and phosphorylated tau in CSF as markers for early-onset Alzheimer disease. Neurology. 2004;62:1580\u20134.","journal-title":"Neurology"},{"key":"2753_CR13","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.jalz.2019.03.009","volume":"15","author":"A Vergallo","year":"2019","unstructured":"Vergallo A, M\u00e9gret L, Lista S, Cavedo E, Zetterberg H, Blennow K, et al. Plasma amyloid \u03b2 40\/42 ratio predicts cerebral amyloidosis in cognitively normal individuals at risk for Alzheimer\u2019s disease. Alzheimers Dement. 2019;15:764\u201375.","journal-title":"Alzheimers Dement"},{"key":"2753_CR14","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1002\/alz.12301","volume":"17","author":"AM Brickman","year":"2021","unstructured":"Brickman AM, Manly JJ, Honig LS, Sanchez D, Reyes\u2010Dumeyer D, Lantigua RA, et al. Plasma p\u2010tau181, p\u2010tau217, and other blood\u2010based Alzheimer\u2019s disease biomarkers in a multi\u2010ethnic, community study. Alzheimers Dement. 2021;17:1353\u201364.","journal-title":"Alzheimers Dement"},{"key":"2753_CR15","first-page":"434","volume":"144","author":"A Keshavan","year":"2021","unstructured":"Keshavan A, Pannee J, Karikari TK, Rodriguez JL, Ashton NJ, Nicholas JM, et al. Population-based blood screening for preclinical Alzheimer\u2019s disease in a British birth cohort at age 70. Brain. 2021;144:434\u201349.","journal-title":"Brain"},{"key":"2753_CR16","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1001\/jamaneurol.2018.0821","volume":"75","author":"T Hohman","year":"2018","unstructured":"Hohman T, Dumitrescu L, Barnes L, Thambisetty M, Beecham G, Kunkle B, et al. Sex-Specific Association of Apolipoprotein E with Cerebrospinal Fluid Levels of Tau. JAMA Neurol. 2018;75:989\u201398.","journal-title":"JAMA Neurol"},{"key":"2753_CR17","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/ana.25878","volume":"88","author":"RF Buckley","year":"2020","unstructured":"Buckley RF, Scott MR, Jacobs HI, Schultz AP, Properzi MJ, Amarglio RE, et al. Sex mediates relationships between regional tau pathology and cognitive decline. Ann Neurol. 2020;88:921\u201332.","journal-title":"Ann Neurol"},{"key":"2753_CR18","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s11682-016-9523-8","volume":"11","author":"MEI Koran","year":"2017","unstructured":"Koran MEI, Wagener M, Hohman TJ. Sex differences in the association between AD biomarkers and cognitive decline. Brain Imaging Behav. 2017;11:205\u201313.","journal-title":"Brain Imaging Behav"},{"key":"2753_CR19","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1001\/archpsyc.62.6.685","volume":"62","author":"LL Barnes","year":"2005","unstructured":"Barnes LL, Wilson RS, Bienias JL, Schneider JA, Evans DA, Bennett DA. Sex differences in the clinical manifestations of Alzheimer disease pathology. Arch Gen Psychiatry. 2005;62:685\u201391.","journal-title":"Arch Gen Psychiatry"},{"key":"2753_CR20","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s00401-018-1920-1","volume":"136","author":"S Oveisgharan","year":"2018","unstructured":"Oveisgharan S, Arvanitakis Z, Yu L, Farfel J, Schneider JA, Bennett DA. Sex differences in Alzheimer\u2019s disease and common neuropathologies of aging. Acta Neuropathologica. 2018;136:887\u2013900.","journal-title":"Acta Neuropathologica"},{"key":"2753_CR21","first-page":"103","volume":"1","author":"KA Lin","year":"2015","unstructured":"Lin KA, Choudhury KR, Rathakrishnan BG, Marks DM, Petrella JR, Doraiswamy PM. et al. Marked gender differences in progression of mild cognitive impairment over 8 years. Alzheimers Dement. 2015;1:103\u201310.","journal-title":"Alzheimers Dement."},{"key":"2753_CR22","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.3174\/ajnr.A3601","volume":"34","author":"D Holland","year":"2013","unstructured":"Holland D, Desikan RS, Dale AM, McEvoy LK. Higher rates of decline for women and apolipoprotein E \u03b54 carriers. Am J Neuroradiol. 2013;34:2287\u201393.","journal-title":"Am J Neuroradiol"},{"key":"2753_CR23","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","volume":"17","author":"F Leng","year":"2021","unstructured":"Leng F, Edison P. Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here? Nat Rev Neurol. 2021;17:157\u201372.","journal-title":"Nat Rev Neurol"},{"key":"2753_CR24","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202012308","volume":"12","author":"M Ewers","year":"2020","unstructured":"Ewers M, Biechele G, Su\u00e1rez\u2010Calvet M, Sacher C, Blume T, Morenas\u2010Rodriguez E, et al. Higher CSF sTREM2 and microglia activation are associated with slower rates of beta\u2010amyloid accumulation. EMBO Mol Med. 2020;12:e12308.","journal-title":"EMBO Mol Med"},{"key":"2753_CR25","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S1474-4422(22)00027-8","volume":"21","author":"E Morenas-Rodr\u00edguez","year":"2022","unstructured":"Morenas-Rodr\u00edguez E, Li Y, Nuscher B, Franzmeier N, Xiong C, Su\u00e1rez-Calvet M, et al. Soluble TREM2 in CSF and its association with other biomarkers and cognition in autosomal-dominant Alzheimer\u2019s disease: a longitudinal observational study. Lancet Neurol. 2022;21:329\u201341.","journal-title":"Lancet Neurol"},{"key":"2753_CR26","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.jalz.2016.06.005","volume":"12","author":"JD Gispert","year":"2016","unstructured":"Gispert JD, Su\u00e1rez-Calvet M, Mont\u00e9 GC, Tucholka A, Falcon C, Rojas S, et al. Cerebrospinal fluid sTREM2 levels are associated with gray matter volume increases and reduced diffusivity in early Alzheimer\u2019s disease. Alzheimers Dement. 2016;12:1259\u201372.","journal-title":"Alzheimers Dement"},{"key":"2753_CR27","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1038\/s43587-022-00310-z","volume":"2","author":"JB Pereira","year":"2022","unstructured":"Pereira JB, Janelidze S, Strandberg O, Whelan CD, Zetterberg H, Blennow K, et al. Microglial activation protects against accumulation of tau aggregates in nondemented individuals with underlying Alzheimer\u2019s disease pathology. Nat Aging. 2022;2:1138\u201344.","journal-title":"Nat Aging"},{"key":"2753_CR28","doi-asserted-by":"crossref","first-page":"eaav6221","DOI":"10.1126\/scitranslmed.aav6221","volume":"11","author":"M Ewers","year":"2019","unstructured":"Ewers M, Franzmeier N, Su\u00e1rez-Calvet M, Morenas-Rodriguez E, Caballero MAA, Kleinberger G, et al. Increased soluble TREM2 in cerebrospinal fluid is associated with reduced cognitive and clinical decline in Alzheimer\u2019s disease. Sci Transl Med. 2019;11:eaav6221.","journal-title":"Sci Transl Med"},{"key":"2753_CR29","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202216987","volume":"15","author":"D Biel","year":"2023","unstructured":"Biel D, Su\u00e1rez\u2010Calvet M, Hager P, Rubinski A, Dewenter A, Steward A, et al. sTREM2 is associated with amyloid\u2010related p\u2010tau increases and glucose hypermetabolism in Alzheimer\u2019s disease. EMBO Mol Med. 2023;15:e16987.","journal-title":"EMBO Mol Med"},{"key":"2753_CR30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-018-0301-5","volume":"14","author":"M Su\u00e1rez-Calvet","year":"2019","unstructured":"Su\u00e1rez-Calvet M, Morenas-Rodr\u00edguez E, Kleinberger G, Schlepckow K, Araque Caballero M\u00c1, Franzmeier N, et al. Early increase of CSF sTREM2 in Alzheimer\u2019s disease is associated with tau related-neurodegeneration but not with amyloid-\u03b2 pathology. Mol Neurodegeneration. 2019;14:1\u201314.","journal-title":"Mol Neurodegeneration"},{"key":"2753_CR31","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.celrep.2019.03.099","volume":"27","author":"CS Frigerio","year":"2019","unstructured":"Frigerio CS, Wolfs L, Fattorelli N, Thrupp N, Voytyuk I, Schmidt I, et al. The major risk factors for Alzheimer\u2019s disease: age, sex, and genes modulate the microglia response to A\u03b2 plaques. Cell Rep. 2019;27:1293\u2013306.e6.","journal-title":"Cell Rep"},{"key":"2753_CR32","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/s42003-021-02259-y","volume":"4","author":"M-V Guillot-Sestier","year":"2021","unstructured":"Guillot-Sestier M-V, Araiz AR, Mela V, Gaban AS, O\u2019Neill E, Joshi L, et al. Microglial metabolism is a pivotal factor in sexual dimorphism in Alzheimer\u2019s disease. Commun Biol. 2021;4:711.","journal-title":"Commun Biol"},{"key":"2753_CR33","doi-asserted-by":"crossref","DOI":"10.1186\/s40478-019-0729-z","volume":"7","author":"T Stephen","year":"2019","unstructured":"Stephen T, Cacciottolo M, Balu D, Morgan T, LaDu M, Finch C, et al. APOE genotype and sex affect microglial interactions with plaques in Alzheimer\u2019s disease mice. Acta Neuropathologica Commun. 2019;7:82.","journal-title":"Acta Neuropathologica Commun"},{"key":"2753_CR34","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1007\/s12264-018-0268-9","volume":"34","author":"JT Yang","year":"2018","unstructured":"Yang JT, Wang ZJ, Cai HY, Yuan L, Hu MM, Wu MN, et al. Sex Differences in Neuropathology and Cognitive Behavior in APP\/PS1\/tau Triple-Transgenic Mouse Model of Alzheimer\u2019s Disease. Neurosci Bull. 2018;34:736\u201346.","journal-title":"Neurosci Bull"},{"key":"2753_CR35","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/alz.12245","volume":"17","author":"G Salvad\u00f3","year":"2021","unstructured":"Salvad\u00f3 G, Mil\u00e0\u2010Alom\u00e0 M, Shekari M, Minguillon C, Fauria K, Ni\u00f1erola\u2010Baiz\u00e1n A, et al. Cerebral amyloid\u2010\u03b2 load is associated with neurodegeneration and gliosis: Mediation by p\u2010tau and interactions with risk factors early in the Alzheimer\u2019s continuum. Alzheimers Dement. 2021;17:788\u2013800.","journal-title":"Alzheimers Dement"},{"key":"2753_CR36","doi-asserted-by":"crossref","first-page":"e064811","DOI":"10.1002\/alz.064811","volume":"18","author":"Y Yakoub","year":"2022","unstructured":"Yakoub Y, Ashton NJ, Karikari TK, Strikwerda\u2010Brown C, Montoliu\u2010Gaya L, Meyer PF, et al. Longitudinal blood biomarker trajectories in preclinical Alzheimer\u2019s disease. Alzheimers Dement. 2022;18:e064811.","journal-title":"Alzheimers Dement"},{"key":"2753_CR37","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/alz.12447","volume":"18","author":"P Chatterjee","year":"2022","unstructured":"Chatterjee P, Pedrini S, Ashton NJ, Tegg M, Goozee K, Singh AK, et al. Diagnostic and prognostic plasma biomarkers for preclinical Alzheimer\u2019s disease. Alzheimers Dement. 2022;18:1141\u201354.","journal-title":"Alzheimers Dement"},{"key":"2753_CR38","doi-asserted-by":"crossref","first-page":"3536","DOI":"10.1093\/brain\/awac257","volume":"145","author":"KB Casaletto","year":"2022","unstructured":"Casaletto KB, Nichols E, Aslanyan V, Simone SM, Rabin JS, La Joie R, et al. Sex-specific effects of microglial activation on Alzheimer\u2019s disease proteinopathy in older adults. Brain. 2022;145:3536\u201345.","journal-title":"Brain"},{"key":"2753_CR39","first-page":"82","volume":"2","author":"JL Molinuevo","year":"2016","unstructured":"Molinuevo JL, Gramunt N, Gispert JD, Fauria K, Esteller M, Minguillon C, et al. The ALFA project: A research platform to identify early pathophysiological features of Alzheimer\u2019s disease. Alzheimers Dement 2016;2:82\u201392.","journal-title":"Alzheimers Dement"},{"key":"2753_CR40","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/hbm.22627","volume":"36","author":"PA Yushkevich","year":"2015","unstructured":"Yushkevich PA, Pluta JB, Wang H, Xie L, Ding SL, Gertje EC, et al. Automated volumetry and regional thickness analysis of hippocampal subfields and medial temporal cortical structures in mild cognitive impairment. Hum Brain Mapp. 2015;36:258\u201387.","journal-title":"Hum Brain Mapp"},{"key":"2753_CR41","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.633438","volume":"15","author":"J Huguet","year":"2021","unstructured":"Huguet J, Falcon C, Fust\u00e9 D, Girona S, Vicente D, Molinuevo JL, et al. Management and quality control of large neuroimaging datasets: developments from the Barcelona\u03b2eta Brain Research Center. Front Neurosci. 2021;15:633438.","journal-title":"Front Neurosci"},{"key":"2753_CR42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2014.07.003","volume":"11","author":"WE Klunk","year":"2015","unstructured":"Klunk WE, Koeppe RA, Price JC, Benzinger TL, Devous MD Sr, Jagust WJ, et al. The Centiloid Project: standardizing quantitative amyloid plaque estimation by PET. Alzheimer\u2019s Dement. 2015;11:1\u201315.e4.","journal-title":"Alzheimer\u2019s Dement"},{"key":"2753_CR43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-018-0453-0","volume":"11","author":"G Salvad\u00f3","year":"2019","unstructured":"Salvad\u00f3 G, Molinuevo JL, Brugulat-Serrat A, Falcon C, Grau-Rivera O, Su\u00e1rez-Calvet M, et al. Centiloid cut-off values for optimal agreement between PET and CSF core AD biomarkers. Alzheimers Res Ther. 2019;11:1\u201312.","journal-title":"Alzheimers Res Ther"},{"key":"2753_CR44","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S1474-4422(14)70194-2","volume":"13","author":"JrCR Jack","year":"2014","unstructured":"Jack JrCR, Wiste HJ, Weigand SD, Rocca WA, Knopman DS, Mielke MM, et al. Age-specific population frequencies of amyloidosis and neurodegeneration among cognitively normal people age 50-89 years: a cross-sectional study. Lancet Neurol. 2014;13:997.","journal-title":"Lancet Neurol"},{"key":"2753_CR45","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1002\/alz.12131","volume":"16","author":"M Mil\u00e0\u2010Alom\u00e0","year":"2020","unstructured":"Mil\u00e0\u2010Alom\u00e0 M, Salvad\u00f3 G, Gispert JD, Vilor\u2010Tejedor N, Grau\u2010Rivera O, Sala\u2010Vila A, et al. Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer\u2019s continuum. Alzheimers Dement. 2020;16:1358\u201371.","journal-title":"Alzheimers Dement"},{"key":"2753_CR46","doi-asserted-by":"crossref","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B Methodological. 1995;57:289\u2013300.","DOI":"10.1111\/j.2517-6161.1995.tb02031.x"},{"key":"2753_CR47","doi-asserted-by":"crossref","first-page":"8098","DOI":"10.1073\/pnas.90.17.8098","volume":"90","author":"WJ Strittmatter","year":"1993","unstructured":"Strittmatter WJ, Weisgraber KH, Huang DY, Dong L-M, Salvesen GS, Pericak-Vance M, et al. Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc Natl Acad Sci. 1993;90:8098\u2013102.","journal-title":"Proc Natl Acad Sci"},{"key":"2753_CR48","volume":"9","author":"JP Ferrari-Souza","year":"2023","unstructured":"Ferrari-Souza JP, Lussier FZ, Leffa DT, Therriault J, Tissot C, Bellaver B, et al. APOE \u03b54 associates with microglial activation independently of A\u03b2 plaques and tau tangles. Sci Adv. 2023;9:eade1474.","journal-title":"Sci Adv"},{"key":"2753_CR49","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1038\/s41591-023-02380-x","volume":"29","author":"B Bellaver","year":"2023","unstructured":"Bellaver B, Povala G, Ferreira PCL, Ferrari-Souza JP, Leffa DT, Lussier FZ, et al. Astrocyte reactivity influences amyloid-\u03b2 effects on tau pathology in preclinical Alzheimer\u2019s disease. Nat Med. 2023;29:1775\u201381.","journal-title":"Nat Med"},{"key":"2753_CR50","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1038\/s41380-022-01716-2","volume":"27","author":"JP Ferrari-Souza","year":"2022","unstructured":"Ferrari-Souza JP, Ferreira PCL, Bellaver B, Tissot C, Wang Y-T, Leffa DT, et al. Astrocyte biomarker signatures of amyloid-\u03b2 and tau pathologies in Alzheimer\u2019s disease. Mol Psychiatry. 2022;27:4781\u20139.","journal-title":"Mol Psychiatry"},{"key":"2753_CR51","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1001\/jamaneurol.2018.4693","volume":"76","author":"RF Buckley","year":"2019","unstructured":"Buckley RF, Mormino EC, Rabin JS, Hohman TJ, Landau S, Hanseeuw BJ, et al. Sex Differences in the Association of Global Amyloid and Regional Tau Deposition Measured By Positron Emission Tomography in Clinically Normal Older Adults. JAMA Neurol. 2019;76:542\u201351.","journal-title":"JAMA Neurol"},{"key":"2753_CR52","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.brainresbull.2023.02.008","volume":"195","author":"SR Oca\u00f1as","year":"2023","unstructured":"Oca\u00f1as SR, Ansere VA, Kellogg CM, Isola JV, Chucair-Elliott AJ, Freeman WM. Chromosomal and gonadal factors regulate microglial sex effects in the aging brain. Brain Res Bull. 2023;195:157\u201371.","journal-title":"Brain Res Bull"},{"key":"2753_CR53","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1093\/jnen\/nlab085","volume":"80","author":"CM Kloske","year":"2021","unstructured":"Kloske CM, Dugan AJ, Weekman EM, Winder Z, Patel E, Nelson PT, et al. Inflammatory Pathways Are Impaired in Alzheimer Disease and Differentially Associated With Apolipoprotein E Status. J Neuropathol Exp Neurol. 2021;80:922\u201332.","journal-title":"J Neuropathol Exp Neurol"},{"key":"2753_CR54","volume":"17","author":"CM Kloske","year":"2021","unstructured":"Kloske CM, Weekman EM, Xie K, Patel E, Anderson S, Bachstetter AD, et al. APOE-e4 alters the microglial phenotype in the presence of Alzheimer\u2019s disease pathology compared to APOE-e3. Alzheimers Dement. 2021;17:e055489.","journal-title":"Alzheimers Dement."}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-024-02753-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-024-02753-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-024-02753-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T04:03:09Z","timestamp":1742270589000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-024-02753-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,9]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["2753"],"URL":"https:\/\/doi.org\/10.1038\/s41380-024-02753-9","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,9]]},"assertion":[{"value":"19 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"CV-C, MA, EP, PA-D, GO, KB, JD-G, CF, KFC and EMAU report no conflict of interest. HZ has served at scientific advisory boards and\/or as a consultant for Abbvie, Acumen, Alector, Alzinova, ALZPath, Annexon, Apellis, Artery Therapeutics, AZTherapies, Cognito Therapeutics, CogRx, Denali, Eisai, Merry Life, Nervgen, Novo Nordisk, Optoceutics, Passage Bio, Pinteon Therapeutics, Prothena, Red Abbey Labs, reMYND, Roche, Samumed, Siemens Healthineers, Triplet Therapeutics, and Wave, has given lectures in symposia sponsored by Alzecure, Biogen, Cellectricon, Fujirebio, Lilly, and Roche, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program (outside submitted work). OG-R has given lectures in symposia sponsored by Roche Diagnostics, and receives support for research (to the institution) from F- Hoffmann La Roche. GK is a full\u2011time employee of Roche Diagnostics GmbH. CQ-R is a full\u2011time employee of Roche Diagnostics International Ltd. MS-C has given lectures in symposia sponsored by Roche Diagnostics, S.L.U, Roche Farma, S.A, Eli Lilly and Amirall, he has served as a consultant and at advisory boards for Roche Diagnostics International Ltd and Grifols S.L. He was granted with a project funded by Roche Diagnostics International Ltd. All payments were made to the institution (BBRC). He received in-kind support for research (to the institution) from Roche Diagnostics International Ltd, Avid Radiopharmaceuticals, Inc., Eli Lilly and Janssen Research & Development.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}